4//SEC Filing
Zhang Yizhuo 4
Accession 0000899243-20-014470
CIK 0001383701other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 7:50 PM ET
Size
6.0 KB
Accession
0000899243-20-014470
Insider Transaction Report
Form 4
Histogen Inc.HSTO
Zhang Yizhuo
Director
Transactions
- Other
Common Stock
2020-05-26+600,983→ 600,983 total(indirect: See footnote)
Footnotes (2)
- [F1]Shares of common stock of the corporation formerly known as Histogen Inc. ("Histogen") were converted into shares of common stock of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of January 28, 2020, by and among the Issuer, Chinook Merger Sub, Inc. and Histogen (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of Histogen common stock was exchanged for 1.4342 shares of the Issuer's common stock (the "Conversion"). Immediately following the merger, the Issuer changed its name to Histogen Inc. All share numbers reflect the one-for-ten reverse stock split (the "Reverse Split") effected by the Issuer immediately prior to the completion of the merger.
- [F2]Consists of shares held by Pineworld Capital Limited ("Pineworld"). Mr. Zhang is the Investment Director of Pineworld and has voting power over the shares held by Pineworld.
Documents
Issuer
Histogen Inc.
CIK 0001383701
Entity typeother
Related Parties
1- filerCIK 0001810103
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 7:50 PM ET
- Size
- 6.0 KB